معرفی
Shane Lloyd, MD, is an Associate Professor in the Department of Radiation Oncology at the University of Utah School of Medicine, affiliated with Huntsman Cancer Institute. He specializes in treating gastrointestinal, head/neck, and genitourinary cancers. His research emphasizes improving care quality through data analysis, clinical trials, and addressing health disparities in cancer survivorship.
Education:
- M.D. & M.H.S. from Yale School of Medicine
- B.A. in Economics and Zoology from Brigham Young University
- Residency in Radiation Oncology at Yale New Haven Hospital
- Internship at University of Utah Affiliated Hospitals
Research Focus: Dr. Lloyd investigates radiation therapy optimization, cancer survivorship outcomes, and socio-geographic health disparities. His work integrates population-based data analytics to evaluate treatment efficacy, mental health impacts, and equitable care access.
Publications: Recent articles (2022–2025) highlight trends in prostate, bladder, and gastrointestinal oncology, with emphasis on immunotherapy combinations, survivorship disparities, and biomarker-driven recurrence detection. Machine learning applications in treatment decision-making and rural health inequities are recurring themes.
Leadership: Chairs the Radiological Drug Research Committee (RDRC) and Human Use Subcommittee of the Radiation Safety Committee (HUS-RSC).
